Fernando F. Blanco

1.3k total citations
25 papers, 1.0k citations indexed

About

Fernando F. Blanco is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Fernando F. Blanco has authored 25 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Fernando F. Blanco's work include RNA modifications and cancer (9 papers), RNA Research and Splicing (8 papers) and Pancreatic and Hepatic Oncology Research (5 papers). Fernando F. Blanco is often cited by papers focused on RNA modifications and cancer (9 papers), RNA Research and Splicing (8 papers) and Pancreatic and Hepatic Oncology Research (5 papers). Fernando F. Blanco collaborates with scholars based in United States, Spain and Switzerland. Fernando F. Blanco's co-authors include Dan A. Dixon, Sandhya Sanduja, Jonathan R. Brody, Jordan M. Winter, Saswati N. Chand, Annalisa Bruno, Paola Patrignani, Masaya Jimbo, Kevin O’Hayer and Charles J. Yeo and has published in prestigious journals such as Gastroenterology, Molecular and Cellular Biology and Cancer Research.

In The Last Decade

Fernando F. Blanco

25 papers receiving 997 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fernando F. Blanco United States	16	583	293	284	124	114	25	1.0k
Janis de la Iglesia-Vicente Spain	15	592 1.0×	214 0.7×	181 0.6×	97 0.8×	93 0.8×	19	1.0k
Michal Stark Israel	18	627 1.1×	279 1.0×	147 0.5×	98 0.8×	56 0.5×	31	1.1k
Ana Mitrović Slovenia	15	340 0.6×	216 0.7×	186 0.7×	55 0.4×	83 0.7×	42	837
Michael J. Absalon United States	14	941 1.6×	427 1.5×	130 0.5×	73 0.6×	92 0.8×	34	1.3k
John P. Parisot Australia	13	425 0.7×	193 0.7×	221 0.8×	99 0.8×	37 0.3×	18	802
Lalitha Ramanathapuram United States	15	416 0.7×	341 1.2×	141 0.5×	93 0.8×	247 2.2×	17	880
Mayuko Omori United States	10	883 1.5×	294 1.0×	122 0.4×	37 0.3×	76 0.7×	14	1.2k
Mads H. Haugen Norway	18	856 1.5×	227 0.8×	320 1.1×	109 0.9×	132 1.2×	40	1.2k
Piotr Zawierucha Poland	16	521 0.9×	279 1.0×	238 0.8×	83 0.7×	85 0.7×	40	893
Peter H. Clingen United Kingdom	13	690 1.2×	223 0.8×	245 0.9×	40 0.3×	88 0.8×	17	990

Countries citing papers authored by Fernando F. Blanco

Since Specialization

Citations

This map shows the geographic impact of Fernando F. Blanco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fernando F. Blanco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fernando F. Blanco more than expected).

Fields of papers citing papers by Fernando F. Blanco

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fernando F. Blanco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fernando F. Blanco. The network helps show where Fernando F. Blanco may publish in the future.

Co-authorship network of co-authors of Fernando F. Blanco

This figure shows the co-authorship network connecting the top 25 collaborators of Fernando F. Blanco. A scholar is included among the top collaborators of Fernando F. Blanco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fernando F. Blanco. Fernando F. Blanco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chervoneva, Inna, Susan Adeniyi-Jones, Fernando F. Blanco, & Walter K. Kraft. (2020). Development of an abbreviated symptom score for the neonatal abstinence syndrome. Journal of Perinatology. 40(7). 1031–1040. 7 indexed citations

Blanco, Fernando F., et al.. (2019). Impact of different fucoidans on pathological pathways activated in osteoarthritic articular cells. Osteoarthritis and Cartilage. 27. S147–S148. 3 indexed citations

Zarei, Mahsa, Shruti Lal, Seth J. Parker, et al.. (2017). Posttranscriptional Upregulation of IDH1 by HuR Establishes a Powerful Survival Phenotype in Pancreatic Cancer Cells. Cancer Research. 77(16). 4460–4471. 84 indexed citations

Tchekmedyian, Nishan, Raja Mudad, Fernando F. Blanco, et al.. (2017). Longitudinal monitoring of ctDNA EGFR mutation burden from urine correlates with patient response to EGFR TKIs: A case series. Lung Cancer. 108. 22–28. 21 indexed citations

Chand, Saswati N., Kevin O’Hayer, Fernando F. Blanco, Jordan M. Winter, & Jonathan R. Brody. (2016). The Landscape of Pancreatic Cancer Therapeutic Resistance Mechanisms. International Journal of Biological Sciences. 12(3). 273–282. 89 indexed citations

Zhou, Honglei, Aristeidis G. Telonis, Jing Yi, et al.. (2016). GPRC5A is a potential oncogene in pancreatic ductal adenocarcinoma cells that is upregulated by gemcitabine with help from HuR. Cell Death and Disease. 7(7). e2294–e2294. 41 indexed citations

Chen, Inna M., Victoria M. Raymond, Jennifer A. Geis, et al.. (2016). Abstract A20: Detection and quantification of ctDNA KRAS mutations from patients with unresectable pancreatic cancer. Cancer Research. 76(24_Supplement). A20–A20. 1 indexed citations

Jimbo, Masaya, Fernando F. Blanco, Aristeidis G. Telonis, et al.. (2015). Targeting the mRNA-binding protein HuR impairs malignant characteristics of pancreatic ductal adenocarcinoma cells. Oncotarget. 6(29). 27312–27331. 41 indexed citations

Blanco, Fernando F., Masaya Jimbo, Jing Deng, et al.. (2015). The mRNA-binding protein HuR promotes hypoxia-induced chemoresistance through posttranscriptional regulation of the proto-oncogene PIM1 in pancreatic cancer cells. Oncogene. 35(19). 2529–2541. 100 indexed citations

10.

Sobolewski, Cyril, et al.. (2015). Histone Deacetylase Inhibitors Activate Tristetraprolin Expression through Induction of Early Growth Response Protein 1 (EGR1) in Colorectal Cancer Cells. Biomolecules. 5(3). 2035–2055. 32 indexed citations

11.

Blanco, Fernando F., et al.. (2015). Tamoxifen Prevents Apoptosis and Follicle Loss from Cyclophosphamide in Cultured Rat Ovaries1. Biology of Reproduction. 92(5). 132–132. 38 indexed citations

12.

Kozak, Geoffrey M., Fernando F. Blanco, & Jonathan R. Brody. (2014). Novel Targets in Pancreatic Cancer Research. Seminars in Oncology. 42(1). 177–187. 17 indexed citations

13.

Tholey, Renee, Shruti Lal, Masaya Jimbo, et al.. (2014). MUC1 Promoter–Driven DTA as a Targeted Therapeutic Strategy against Pancreatic Cancer. Molecular Cancer Research. 13(3). 439–448. 18 indexed citations

14.

Cozzitorto, Joseph A., Masaya Jimbo, Saswati N. Chand, et al.. (2014). Studying RNA-Binding Protein Interactions with Target mRNAs in Eukaryotic Cells: Native Ribonucleoprotein Immunoprecipitation (RIP) Assays. Methods in molecular biology. 1262. 239–246. 13 indexed citations

15.

Blanco, Fernando F., Sandhya Sanduja, Natasha G. Deane, Perry J. Blackshear, & Dan A. Dixon. (2013). Transforming Growth Factor β Regulates P-Body Formation through Induction of the mRNA Decay Factor Tristetraprolin. Molecular and Cellular Biology. 34(2). 180–195. 36 indexed citations

16.

Dixon, Dan A., Fernando F. Blanco, Annalisa Bruno, & Paola Patrignani. (2012). Mechanistic Aspects of COX-2 Expression in Colorectal Neoplasia. Recent results in cancer research. 191. 7–37. 83 indexed citations

17.

Sanduja, Sandhya, Fernando F. Blanco, & Dan A. Dixon. (2010). The roles of TTP and BRF proteins in regulated mRNA decay. Wiley Interdisciplinary Reviews - RNA. 2(1). 42–57. 133 indexed citations

18.

González-Vadillo, Ana Ma, Amparo Álvarez-Valdés, Victoria Moneo, et al.. (2006). Structure–activity relationship of new trans-platinum(II) and (IV) complexes with cyclohexylamine. Interference with cell cycle progression and induction of cell death. Journal of Inorganic Biochemistry. 101(4). 551–558. 11 indexed citations

19.

Carnero, Amancio, Carmen Blanco‐Aparicio, Fernando F. Blanco, et al.. (2003). Exploring cellular senescence as a tumor suppressor mechanism. 5(5). 249–265. 3 indexed citations

20.

Moreno, Javier, Javier Nieto, Cristina Chamizo, et al.. (1999). The immune response and PBMC subsets in canine visceral leishmaniasis before, and after, chemotherapy. Veterinary Immunology and Immunopathology. 71(3-4). 181–195. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact